Placental Growth Factor for the Treatment of Fetal Alcohol Syndrome Disorder (FASD)

摘要

The present invention is directed to a drug in the prevention and / or treatment of fetal alcohol spectrum disorder (FASD) selected from the group comprising fetal alcohol syndrome (FAS), cerebrovascular disease, and growth retardation in a subject exposed to alcohol in the uterus. Placental growth factor (PlGF) used. The invention also relates to a pharmaceutical composition or product comprising PlGF for the same therapeutic use.